Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Siesjö Immune Brain Advice AB
AB
Active
Org 5595137471
Hökvägen 3, 227 32
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2025
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Siesjö Immune Brain Advice AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
140
Staff expenses
—
EBITDA
43
Depreciation & amort.
—
EBIT
43
Net financials
−0
Profit before tax
42
Tax
−9
Net profit
34
Balance sheet
SEK thousands
Item
2025
Total assets
149
Equity
59
Long-term debt
—
Short-term debt
90
Total debt
90
Financial ratios
5-year trend
EBITDA margin
30.4%
This company
15.8%
Market median
+92% vs market
2025
2025
Equity ratio
39.4%
This company
38.2%
Market median
+3% vs market
2025
2025
Return on equity
57.4%
This company
18.4%
Market median
+212% vs market
2025
2025
Net profit margin
24.1%
This company
8.1%
Market median
+198% vs market
2025
2025
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
2025
2025
Debt / equity
1.54×
This company
0.62×
Market median
-148% vs market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-03 – 2025-12-31
View
PDF
More on Siesjö Immune Brain Advice AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
